glp 1 agonist dpp 4 inhibitor Were DPP-4 inhibitors the original GLP-1s? Cardiovascular effects of the DPP-4
Description
2012;18(Suppl 1):S183S185
Studies had to report outcomes related to bone mineral density, fracture risk, bone healing, or postoperative complications affecting bone health
Evaluate change in BMI after 12 weeks on the maintenance dose
Sustainable weight loss is a gradual process that requires commitment and lifestyle changes
Published in "The Lancet", this study represents one of the most comprehensive evaluations conducted to date
